Clinical Trials Browser

Phase 2 × Locally Advanced Rectal Cancer × HMPL-013 × Clear all

NCT04989855 2021-08-04

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Phase 2 Unknown

Gastrointestinal

Locally Advanced Rectal Cancer